Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
Open Access
- 1 October 2016
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 17 (5) , 1453-1461
Abstract
No abstract availableKeywords
Funding Information
- Cancer Prevention and Research Institute of Texas (RP16028, RP140001, R1201)
- NIH (DK092883, CA183252, CA125123, P50CA126752, CA193235, DK107413)
- National Center for Research Resources grant (S10RR024574)
- National Institute of Allergy and Infectious Diseases (AI036211)
- National Cancer Institute (P30CA125123)
This publication has 31 references indexed in Scilit:
- Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cellsNature Biotechnology, 2015
- Expanding the Biologist’s Toolkit with CRISPR-Cas9Molecular Cell, 2015
- Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cellsBlood, 2015
- Easy quantitative assessment of genome editing by sequence trace decompositionNucleic Acids Research, 2014
- Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editingNature Biotechnology, 2014
- Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas SystemCell, 2013
- The role of mutations in epigenetic regulators in myeloid malignanciesNature Reviews Cancer, 2012
- Comparison of human cord blood engraftment between immunocompromised mouse strainsBlood, 2010
- An RNAi Screen Identifies Msi2 and Prox1 as Having Opposite Roles in the Regulation of Hematopoietic Stem Cell ActivityCell Stem Cell, 2010
- Observation of Antigen-Dependent CD8+ T-Cell/ Dendritic Cell Interactions in VivoCellular Immunology, 2001